scispace - formally typeset
V

Véronique Fauveau

Researcher at French Institute of Health and Medical Research

Publications -  16
Citations -  1639

Véronique Fauveau is an academic researcher from French Institute of Health and Medical Research. The author has contributed to research in topics: Insulin resistance & Insulin receptor. The author has an hindex of 13, co-authored 15 publications receiving 1476 citations. Previous affiliations of Véronique Fauveau include Paris Descartes University & Centre national de la recherche scientifique.

Papers
More filters
Journal ArticleDOI

Hepatic glucokinase is required for the synergistic action of ChREBP and SREBP-1c on glycolytic and lipogenic gene expression.

TL;DR: It is demonstrated that in hGK-KO hepatocytes overexpressing SREBP-1c, the effect of glucose on glycolytic and lipogenic genes is lost because of the impaired ability of these hepatocytes to efficiently metabolize glucose, despite a marked increase in low Km hexokinase activity.
Journal ArticleDOI

Liver-Specific Inhibition of ChREBP Improves Hepatic Steatosis and Insulin Resistance in ob/ob Mice

TL;DR: It is demonstrated that ChREBP is central for the regulation of lipogenesis in vivo and plays a determinant role in the development of the hepatic steatosis and of insulin resistance in ob/ob mice.
Journal ArticleDOI

Diet and Gastrointestinal Bypass-Induced Weight Loss The Roles of Ghrelin and Peptide YY

TL;DR: PYY plays a key role in mediating the early weight loss observed post-GIBP, whereas relative PYY deficiency during dieting may compromise weight-loss attempts.
Journal ArticleDOI

A Specific ChREBP and PPARα Cross-Talk Is Required for the Glucose-Mediated FGF21 Response

TL;DR: It is reported that peroxisome-proliferator-activated receptor α (PPARα), a nuclear receptor of the fasting response, is required with the carbohydrate-sensitive transcription factor carbohydrate-responsive element-binding protein (ChREBP) to balance FGF21 glucose response.